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of disputed histogenesis with low-grade malignancy and a marked tendency to local recurrence but
rarely metastasize to distant sites. Few reports have suggested that DFSPs may enlarge more rapidly
during pregnancy. This article describes a lesion of the atrophic variant of DFSP that increased in size
during pregnancy which is an unusual presentation, and a review of the literature.
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Dermatoﬁbrosarcoma protuberans (DFSPs) are a rare ﬁbro-
blastic mesenchymal skin tumor. The most commonly affected
area is the trunk followed by the extremities, scalp, and neck.
DFSP is a low-grade malignancy of the skin and subcutaneous
tissues with low potential for the developing distant metastases.
The most common presentation is a ﬁrm, indurated plaque,
often skin-colored with red brown exophytic nodules. It also72328.
om
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lseviercan present as a non-protuberant, atrophic, violaceous plaque
resembling morphea. The epidermis may be atrophic and focal
ulceration may occur. Uncommon pigmented variant, called
Bendar tumor, which is an exceedingly rare tumor accounts
for 1–5% of all cases of DFSP. It is characterized by a usually
scant (1–5% of cells) population of dendritic melanocytes
within an otherwise typical DFSP. Less than 5% of DFSPs
are associated with metastases and many of these show either
a ﬁbrosarcomatous component or, much more rarely,
malignant ﬁbrous histocytoma [MFH] ‘‘like appearance’’
(Bisceglia et al., 1997).
There are only few reports in the literature describing
dermatoﬁbrosarcoma protuberans that enlarged considerably
during pregnancy. This article describes a case of the atrophic
variant of DFSP and enlargement of the lesion during
pregnancy which is an unusual presentation.
2. Case presentation
A 30 year old Saudi lady presented on March 21st 2010
complaining of asymptomatic lesion over the left side of the
Figure 2 Mid and deep dermal inﬁltrate extending to fat.
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pregnancy 9 months ago. There was no history of trauma,
bleeding or discharge. She had 6 · 5 cm ﬁrm subcutaneous
tumor with an overlying central depressed atrophic brownish
tethered morphea like skin, in the left side of the upper
abdomen with a visible nodule at the upper edge of the lesion.
The tumor is mobile and not ﬁxed to deeper structures (Fig. 1)
and lymph nodes were not palpable.
Routine blood count, renal function, liver function tests,
ANA and CT chest were all normal.
Skin biopsy showed poorly circumscribed proliferation of
spindle cells that are arranged in interlacing fascicles producing
storiform pattern, inﬁltrating the subcutaneous fat and
isolating adipocytes forming honey comb or swiss cheese
pattern (Figs. 2 and 3). CD34 staining is strongly positive in
the spindle cell (Fig. 4). Immunohistochemical studies were
negative for factor XIIIa, estrogen and progesterone receptors.
3. Discussion
Dermatoﬁbrosarcoma protuberans (DFSPs) were ﬁrst
described by Darier and Ferrand in 1924 and named by
Hoffmann in 1925. The tumor usually occurs in adults of
age 20–50 years. Rarely, DFSP has been reported in newborns
and elderly individuals (Thornton et al., 2005).
The most common location is the trunk (62%), followed by
the extremities (25%) and the head and neck regions (13%)
(Lindner et al., 1999). DFSP is an uncommon skin tumor with
a high potential for local recurrence if not adequately excised.
Most local recurrences, which can occur in 20–49% of cases,
are noted within the ﬁrst 3 years after excision, but late
recurrence has been reported as well (Gloster, 1996). The
recurrence rate is the highest in DFSP of the head and neck
because of cosmetic and functional restrictions of resecting
large areas (Gloster, 1996). The greater the number of
recurrences the more likely the tumor is to disseminateFigure 1 Depressed atrophic skin overlying 5 · 6 cm tumor.
Figure 3 Oval and small cells inﬁltrating the collagen bundles.(Lindner et al., 1999). Metastases are rare. A review of 913
cases of DFSP described regional lymph node metastases in
about 1% and distant metastases in approximately 4%
(Gloster, 1996). The lungs are the most frequent site of
metastases, but metastases to brain, bone, and heart have also
been reported (Garcia et al., 1996). Metastases usually occur
within 6 years (Lindner et al., 1999). DFSP is genetically
characterized by the unbalanced chromosomal translocation
t(17;22) (q21;q13), usually in the form of a supernumerary ring
chromosome. The product of this chromosomal translocation
Figure 4 CD34 stain strongly positive in the spindle cells.
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I-platelet-derived growth factor beta), which is ampliﬁed at
low levels in the ring chromosome which triggers the prolifera-
tion of DFSP tumor cells through PDGF receptor tyrosine
kinase (Abbott et al., 2006).
Imatinib is an oral class of medications called protein-
tyrosine kinase inhibitors that inhibits the platelet-derived
growth factor receptor (PDGF-R) signaling cascade which
plays a crucial role in the pathogenesis and tumor growth of
DFSP. Imatinib mesylate is indicated for the treatment of adult
patients with unresectable, recurrent, and/or metastatic DFSP.
A response rate of approximately 65% has been achieved
among DFSP patients treated with imatinib (McArthur, 2007).
Mohs micrographic surgery (MMS) with a surgical margin
of 2.5 cm deep to fascia may be the treatment of choice for
DFSP, because of its high cure rate and maximal conservation
of tissue. As reported in many studies the recurrence rate by
MMS was 0.6–1.6%, while the average recurrence rate was
18% when DFSP was treated with wide excision (Gloster
et al., 1996).
There are only few reports in the literature describing DFSP
that enlarged considerably during pregnancy. In the report of
Har-Shai et al. (1993) they presented 2 patients in whom
dermatoﬁbrosarcoma protuberans appeared and grew rapidly
during pregnancy. Immunohistochemical studies were negative
for estrogen and progesterone receptors. Fibrosarcomatous
change during pregnancy had also been described by Cakir Barising in DFSP on the scalp (Cakir et al., 2003). Three
additional cases of DFSP that showed accelerated growth
during pregnancy were reported by Parlette et al. (1999). The
tumors in all 3 patients, and 4 additional DFSPs from 2 male
and 2 female subjects, showed expression of progesterone
receptor.
Our patient is peculiar in that she showed considerable
enlargement of the tumor during pregnancy. The immuno-
histochemical studies were negative for estrogen and
progesterone receptors similar to the report of Har-Shai et al.
As with many other stromal neoplasms, DFSP appears to
express low levels of hormone receptors, which may be one
factor that accounts for their accelerated growth during
pregnancy.
In conclusion the atrophic variant of DFSP could be
misdiagnosed as morphea, therefore dermatologist should be
aware of this uncommon but characteristic presentation of
DFSP and a close follow up of the lesions during pregnancy
for size changes, and for any sarcomatous deterioration within
the tumor.
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